Lupin share news and announcements

NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap

₹1,928.90₹6.90 (0.36%)BSE ₹1,925.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹1,922.00.

52-week range of traded prices to 23 Oct 2026

₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026

Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters.

Market cap: ₹88,207 Cr105th largest listed
P/E: 16.0
P/E without one-offs: 14.5
P/B: 3.9
Dividend yield: 0.93%
ROE: 27.9%
ROE without one-offs: 30.7%
ROCE: 28.2%
Debt to equity: 0.26
Volume, NSE: 7,02,15655.7% delivered

Lupin board meetings

87 filed, newest first. Page 1 of 2.

Oct 2026
- 19 Oct · Board meeting
  To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026. (opens in a new tab)
Jul 2026
- 22 Jul · Board meeting
  To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026. (opens in a new tab)
Apr 2026
- 22 Apr · Board meeting
  To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026, and recommend dividend, if any. (opens in a new tab)
Jan 2026
- 28 Jan · Board meeting
  To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2025 and other business matters. (opens in a new tab)
Oct 2025
- 22 Oct · Board meeting
  To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2025. (opens in a new tab)
Jul 2025
- 21 Jul · Board meeting
  To consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter Ended June 30, 2025. (opens in a new tab)
Apr 2025
- 29 Apr · Board meeting
  To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025, and recommend dividend, if any. (opens in a new tab)
Mar 2025
- 31 Mar · Board meeting
  Outcome of Board Meeting held on March 31, 2025. (opens in a new tab)
Feb 2025
- 12 Feb · Board meeting
  Outcome of Board Meeting held on February 11, 2025. (opens in a new tab)
Jan 2025
- 27 Jan · Board meeting
  To consider and approve the unaudited Standalone and Consolidated financial results for the quarter and nine months ended December 31, 2024 and other business matters. (opens in a new tab)
Oct 2024
- 22 Oct · Board meeting
  Board Meeting Intimation for considering and taking on record the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2024 and other business matters. (opens in a new tab)
Jul 2024
- 23 Jul · Board meeting
  Considering and taking on record the unaudited financial results of the Company for the quarter ended June 30, 2024 and other business matters. (opens in a new tab)
Apr 2024
- 22 Apr · Board meeting
  Meeting of the Board of Directors of the Company will be held on Monday, May 6, 2024, inter alia, to consider and take on record audited financial results of the Company for the quarter and year-ended March 31, 2024 and recommend dividend, if any, (opens in a new tab)
Jan 2024
- 24 Jan · Board meeting
  To consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine-months ended December 31, 2023 and other business matters. (opens in a new tab)
Oct 2023
- 25 Oct · Board meeting
  To consider and approve the unaudited financial results of the Company for the quarter and half-year ended September 30, 2023 and other business matters. (opens in a new tab)
Aug 2023
- 3 Aug · Board meeting
  Unaudited Financial Results for the quarter ended June 30, 2023, (opens in a new tab)
Jul 2023
- 21 Jul · Board meeting
  To consider and take on record the unaudited financial results ofthe Company for the quarter ended June 30, 2023 and other business matters. (opens in a new tab)
Apr 2023
- 25 Apr · Board meeting
  To consider and take on record the audited financial results of the Company for the quarter and year ended March 31, 2023, and recommend dividend, if any. (opens in a new tab)
Jan 2023
- 25 Jan · Board meeting
  To consider and take on record unaudited financial results of the Company for the quarter and nine-months ended December 31, 2022. (opens in a new tab)
Oct 2022
- 27 Oct · Board meeting
  Board Meeting to be held on 09-Nov-2022 to consider unaudited financial results of the Company for the quarter and half year ended September 30, 2022. and Other business matters (opens in a new tab)
Jul 2022
- 20 Jul · Board meeting
  Board Meeting to be held on August 3, 2022 to consider financial results for the quarter ended June 30, 2022 and Other business matters. (opens in a new tab)
May 2022
- 3 May · Board meeting
  Board Meeting to be held on 18-May-2022 to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2022, recommend dividend, if any and other business matters. (opens in a new tab)
Jan 2022
- 19 Jan · Board meeting
  To consider and and take on record the unaudited financial results of the Company for the quarter and nine-months ended December 31, 2021 and other business matters. (opens in a new tab)
Oct 2021
- 14 Oct · Board meeting
  To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2021 and other business matters. (opens in a new tab)
Jul 2021
- 30 Jul · Board meeting
  To consider and approve inter-alia the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2021 and other matters. (opens in a new tab)
May 2021
- 3 May · Board meeting
  To consider and approve the audited Standalone and Consolidated financial results for the quarter and year ended March 31, 2021, dividend and other business matters (opens in a new tab)
Jan 2021
- 12 Jan · Board meeting
  To consider and approve the financial results for the quarter and nine months ended December 31, 2020 and other business matters. (opens in a new tab)
Oct 2020
- 20 Oct · Board meeting
  To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2020 and other business matters (opens in a new tab)
Jul 2020
- 27 Jul · Board meeting
  To consider and approve the unaudited financial results for the quarter ended Jun 30, 2020 and other business matters. (opens in a new tab)
May 2020
- 29 May · Board meeting
  Board meeting held on May 28, 2020. (opens in a new tab)
- 5 May · Board meeting
  To consider and approve the audited standalone and consolidated financial results for the year ended March 31, 2020 and recommend dividend, if any. (opens in a new tab)
Jan 2020
- 23 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2019 and other business matters (opens in a new tab)
Oct 2019
- 23 Oct · Board meeting
  To consider and take on record unaudited financial results for the quarter ended September 30, 2019 and other business matters. (opens in a new tab)
Jul 2019
- 23 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2019 and other business matters. (opens in a new tab)
Apr 2019
- 26 Apr · Board meeting
  To consider and approve the audited standalone and consolidated financial results for the year ended March 31, 2019, dividend and other business matters. (opens in a new tab)
Jan 2019
- 23 Jan · Board meeting
  To consider and approve the unaudited financial results for the quarter ended December 31, 2018 and other business matters. (opens in a new tab)
Oct 2018
- 16 Oct · Board meeting
  To consider and take on record unaudited financial results for the quarter ended September 30, 2018. (opens in a new tab)
Jul 2018
- 24 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2018 and other business matters. (opens in a new tab)
Apr 2018
- 26 Apr · Board meeting
  To consider and approve the financial results for the period ended March 31, 2018, dividend and other business matters (opens in a new tab)
Jan 2018
- 24 Jan · Board meeting
  Inter alia, to consider and take on record unaudited financial results for the quarter ended December 31 , 2017. (opens in a new tab)
Oct 2017
- 12 Oct · Board meeting
  Inter alia, to consider and take on record unaudited financial results for the quarter ended September 30, 2017. (opens in a new tab)
Jul 2017
- 17 Jul · Board meeting
  Inter alia, to consider and take on record the unaudited financial results for the quarter ended June 30, 2017. (opens in a new tab)
May 2017
- 2 May · Board meeting
  To consider and take on record the audited standalone and consolidated financial results for the year ended March 31, 2017 and recommend dividend if any. (opens in a new tab)
Jan 2017
- 23 Jan · Board meeting
  Inter alia to consider and take on record the unaudited financial results for the quarter ended December 31, 2016 (opens in a new tab)
Oct 2016
- 17 Oct · Board meeting
  Inter alia, to consider and take on record the unaudited financial results for the quarter ended September 30, 2016. (opens in a new tab)
Jul 2016
- 25 Jul · Board meeting
  Inter alia, to consider and take on record the unaudited financial results for the quarter ended June 30, 2016. (opens in a new tab)
May 2016
- 4 May · Board meeting
  Interalia, to consider and take on record the audited standalone and consolidated Financial Results for the year ended March 31, 2016 and recommended dividend, if any. (opens in a new tab)
Jan 2016
- 19 Jan · Board meeting
  Inter alia, to consider and take on record the unaudited financial results for the quarter ended December 31, 2015. (opens in a new tab)
Oct 2015
- 27 Oct · Board meeting
  At the meeting of the Board of Directors held on October 27, 2015, (i) appointed Mr. Jean-Luc Belingard, as Independent Director, for a period of five years, effective October 27, 2015 and Mr. Ramesh Swaminathan, Chief Financial Officer, as Director for a period of five years, effective October 27, 2015. (opens in a new tab)
- 12 Oct · Board meeting
  Inter alia, to consider and take on record the unaudited financial results for the quarter ended September 30, 2015. (opens in a new tab)

Lupin board meetings

Oct 2026

Jul 2026

Apr 2026

Jan 2026

Oct 2025

Jul 2025

Apr 2025

Mar 2025

Feb 2025

Jan 2025

Oct 2024

Jul 2024

Apr 2024

Jan 2024

Oct 2023

Aug 2023

Jul 2023

Apr 2023

Jan 2023

Oct 2022

Jul 2022

May 2022

Jan 2022

Oct 2021

Jul 2021

May 2021

Jan 2021

Oct 2020

Jul 2020

May 2020

Jan 2020

Oct 2019

Jul 2019

Apr 2019

Jan 2019

Oct 2018

Jul 2018

Apr 2018

Jan 2018

Oct 2017

Jul 2017

May 2017

Jan 2017

Oct 2016

Jul 2016

May 2016

Jan 2016

Oct 2015